Olema Pharmaceuticals

OLMANasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$1.053 B

$12.05 +2.12%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$162.5M

Loss-making

Shares outstanding

87,156,961

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#156Lexicon PharmaceuticalsLXRX$1.10B
#157Jade BiosciencesJBIO$1.08B
#158Olema PharmaceuticalsOLMA$1.05B
#159ApnimedAPMD$1.03B
#160Opko HealthOPK$1.02B

Where these numbers come from

Share counts and financials for Olema Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.